Biochemical efficacy in the inhibition of oxidative stress mediated by Enterococcus faecium and Streptococcus bovis isolated from the intestinal microbiota

Technical Summary: Biochemical Efficacy in the Inhibition of Oxidative Stress Mediated by Enterococcus faecium and Streptococcus bovis

Problem Statement
The human gut microbiota is a complex ecosystem essential for physiological homeostasis, immune regulation, and metabolic health. While dysbiosis is linked to various pathologies, the specific biochemical mechanisms by which commensal strains mitigate oxidative stress remain under-explored, particularly regarding species often associated with pathogenicity, such as Streptococcus bovis and Enterococcus faecium. There is a need to characterize the antioxidant, metal-chelating, and protective capabilities of specific isolates from healthy human feces to determine their viability as probiotic candidates capable of preventing oxidative stress-related disorders.

Methodology
The study utilized four isolates of Enterococcus faecium (IM0425, IM0429, IM0431, IM0432) and four isolates of Streptococcus bovis (IM0413, IM0415, IM0418, IM0419), obtained from the fecal samples of 32 healthy individuals in Algeria. Strains were taxonomically identified using the Vitek 2 system and cultivated under anaerobic conditions with 5% CO₂.

The research evaluated five specific in vitro biological activities:

1. Biofilm Production: Assessed using a modified Stepanović method with crystal violet staining in high-glucose BHI broth.
2. Antioxidant Activity: Measured via DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay.
3. Antidiabetic Potential: Evaluated through $\alpha$-amylase inhibition assays.
4. Iron-Chelating Capacity: Determined using ferrozine to measure Fe²⁺ sequestration.
5. Anti-lipid Peroxidation: Assessed using an egg yolk suspension model to measure inhibition of lipid oxidation.
6. Superoxide Anion Scavenging: Quantified via the autoxidation of pyrogallol under alkaline conditions.

Statistical significance was determined using one-way ANOVA followed by Tukey's post hoc test (p ≤ 0.05). Interactions between the most potent strains of each species (E. faecium IM0425 and S. bovis IM0415) were also tested to evaluate synergistic effects.

Key Results

• Biofilm Formation: All isolates demonstrated high biofilm-forming capabilities, significantly outperforming reference strains Lactobacillus plantarum and Escherichia coli. The interaction between E. faecium IM0425 and S. bovis IM0415 yielded the highest biofilm production at 81.51%, suggesting a synergistic or cooperative relationship in mixed-species biofilms.
• Antioxidant Activity: E. faecium strains exhibited superior antioxidant activity (59.09%–61.05%) compared to S. bovis strains (51.13%–53.42%). The combined interaction of E. faecium IM0425 and S. bovis IM0415 resulted in a 60.2% antioxidant yield. While lower than the Vitamin C control (73.03%), these values indicate significant biological potential.
• Iron-Chelating Capacity: Both species showed comparable chelating abilities (55.25%–56.51%), with the co-culture reaching 57.74%. This remains significantly lower than the EDTA control (92.85%) but is considered biologically relevant for limiting Fenton reactions in the gut.
• Anti-lipid Peroxidation: S. bovis isolates generally outperformed E. faecium in inhibiting lipid peroxidation (28.56%–29.36% vs. 25.47%–27.86%). The co-culture achieved 30.83%, still lower than the BHA control (63.85%).
• Superoxide Scavenging: This activity was notably low across all strains (4.06%–6.01%), with the co-culture showing the lowest value (4.06%). This suggests a selective defense mechanism where these strains may rely more on neutralizing other reactive oxygen species (e.g., peroxides) rather than superoxide anions.
• Antidiabetic Activity: Strains showed moderate $\alpha$-amylase inhibition (46.43%–51.56%), with E. faecium performing slightly better than S. bovis. The co-culture yielded 50.16%, remaining below the Sitagliptin control (66.37%).

Significance and Claims
The authors claim that these findings highlight the probiotic potential of specific E. faecium and S. bovis isolates, challenging the traditional view of biofilm formation as solely pathogenic. The study posits that these commensal strains form a "synergistic protective system" when interacting, characterized by:

1. Enhanced Survival: Robust biofilm formation aids in resisting environmental stressors and ensuring gut colonization.
2. Oxidative Stress Mitigation: Through a combination of antioxidant enzyme activity, iron chelation (preventing hydroxyl radical generation), and lipid peroxidation inhibition, these strains can protect host cells from oxidative damage.
3. Metabolic Adaptation: The selective nature of their antioxidant defense (high lipid protection, low superoxide scavenging) suggests an adaptation to the specific redox environment of the intestinal niche.

The paper concludes that while these strains do not match the efficacy of synthetic antioxidants or pharmaceutical controls, their multifaceted defense mechanisms and ability to function synergistically warrant further research into their molecular mechanisms and potential therapeutic applications in managing oxidative stress and metabolic diseases. The study emphasizes that these isolates represent beneficial components of the gut microbiota capable of promoting gut health and preventing oxidative stress-related disorders.